|
1
|
Sandireddy R, Yerra VG, Areti A,
Komirishetty P and Kumar A: Neuroinflammation and oxidative stress
in diabetic neuropathy: Futuristic strategies based on these
targets. Int J Endocrinol. 2014:6749872014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
O'Brien PD, Sakowski SA and Feldman EL:
Mouse models of diabetic neuropathy. ILAR J. 54:259–272. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bae SM, Bae MN, Kim EY, Kim IK, Seo MW,
Shin JK, Cho SR and Jeong GH: Recurrent insulin autoimmune syndrome
caused by α-Lipoic acid in type 2 diabetes. Endocrinol Metab
(Seoul). 28:326–330. 2013. View Article : Google Scholar
|
|
4
|
Oyenihi AB, Ayeleso AO, Mukwevho E and
Masola B: Antioxidant strategies in the management of diabetic
neuropathy. BioMed Res Int. 2015:5150422015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Verdile G, Keane KN, Cruzat VF, Medic S,
Sabale M, Rowles J, Wijesekara N, Martins RN, Fraser PE and
Newsholme P: Inflammation and oxidative stress: The molecular
connectivity between insulin resistance, obesity, and Alzheimer's
disease. Mediators Inflamm. 2015:1058282015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xiao Q, Yang YA, Zhao XY, He LS, Qin Y, He
YH, Zhang GP and Luo JD: Oxidative stress contributes to the
impaired sonic hedgehog pathway in type 1 diabetic mice with
myocardial infarction. Exp Ther Med. 10:1750–1758. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang XW, Liu FQ, Guo JJ, Yao WJ, Li QQ,
Liu TH and Xu LP: Antioxidation and anti-inflammatory activity of
Tang Bi Kang in rats with diabetic peripheral neuropathy. BMC
Complement Altern Med. 15:662015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sato K, Kameda M, Yasuhara T, Agari T,
Baba T, Wang F, Shinko A, Wakamori T, Toyoshima A, Takeuchi H, et
al: Neuroprotective effects of liraglutide for stroke model of
rats. Int J Mol Sci. 14:21513–21524. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Inoue K, Maeda N, Kashine S, Fujishima Y,
Kozawa J, Hiuge-Shimizu A, Okita K, Imagawa A, Funahashi T and
Shimomura I: Short-term effects of liraglutide on visceral fat
adiposity, appetite, and food preference: A pilot study of obese
Japanese patients with type 2 diabetes. Cardiovasc Diabetol.
10:1092011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jaiswal M, Martin CL, Brown MB, Callaghan
B, Albers JW, Feldman EL and Pop-Busui R: Effects of exenatide on
measures of diabetic neuropathy in subjects with type 2 diabetes:
Results from an 18-month proof-of-concept open-label randomized
study. J Diabetes Complications. 29:1287–1294. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jolivalt CG, Fineman M, Deacon CF, Carr RD
and Calcutt NA: GLP-1 signals via ERK in peripheral nerve and
prevents nerve dysfunction in diabetic mice. Diabetes Obes Metab.
13:990–1000. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu WJ, Jin HY, Lee KA, Xie SH, Baek HS
and Park TS: Neuroprotective effect of the glucagon-like peptide-1
receptor agonist, synthetic exendin-4, in streptozotocin-induced
diabetic rats. Br J Pharmacol. 164:1410–1420. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ganesh Yerra V, Negi G, Sharma SS and
Kumar A: Potential therapeutic effects of the simultaneous
targeting of the Nrf2 and NF-κB pathways in diabetic neuropathy.
Redox Biol. 1:394–397. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ramesh G, MacLean AG and Philipp MT:
Cytokines and chemokines at the crossroads of neuroinflammation,
neurodegeneration, and neuropathic pain. Mediators Inflamm.
2013:4807392013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak and Schmittgen: Analysis of relative
gene expression data using real-time quantitative PCR and the
2-ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
16
|
Höke A: Animal models of peripheral
neuropathies. Neurotherapeutics. 9:262–269. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chapter MC, White CM, DeRidder A, Chadwick
W, Martin B and Maudsley S: Chemical modification of class II G
protein-coupled receptor ligands: Frontiers in the development of
peptide analogs as neuroendocrine pharmacological therapies.
Pharmacol Ther. 125:39–54. 2010. View Article : Google Scholar
|
|
18
|
Douglas DS and Popko B: Mouse forward
genetics in the study of the peripheral nervous system and human
peripheral neuropathy. Neurochem Res. 34:124–137. 2009. View Article : Google Scholar :
|
|
19
|
Edwards JL, Vincent AM, Cheng HT and
Feldman EL: Diabetic neuropathy: Mechanisms to management.
Pharmacol Ther. 120:1–34. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lupachyk S, Stavniichuk R, Komissarenko
JI, Drel VR, Obrosov AA, El-Remessy AB, Pacher P and Obrosova IG:
Na+/H+-exchanger-1 inhibition counteracts
diabetic cataract formation and retinal oxidative-nitrative stress
and apoptosis. Int J Mol Med. 29:989–998. 2012.PubMed/NCBI
|
|
21
|
Tesfaye S, Boulton AJ and Dickenson AH:
Mechanisms and management of diabetic painful distal symmetrical
polyneuropathy. Diabetes Care. 36:2456–2465. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Karamoysoyli E, Burnand RC, Tomlinson DR
and Gardiner NJ: Neuritin mediates nerve growth factor-induced
axonal regeneration and is deficient in experimental diabetic
neuropathy. Diabetes. 57:181–189. 2008. View Article : Google Scholar
|
|
23
|
Gorska-Ciebiada M, Saryusz-Wolska M,
Borkowska A, Ciebiada M and Loba J: Serum levels of inflammatory
markers in depressed elderly patients with diabetes and mild
cognitive impairment. PLoS One. 10:e01204332015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zong H, Ward M, Madden A, Yong PH, Limb
GA, Curtis TM and Stitt AW: Hyperglycaemia-induced pro-inflammatory
responses by retinal Müller glia are regulated by the receptor for
advanced glycation end-products (RAGE). Diabetologia. 53:2656–2666.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Heni M, Kullmann S, Gallwitz B, Häring HU,
Preissl H and Fritsche A: Dissociation of GLP-1 and insulin
association with food processing in the brain: GLP-1 sensitivity
despite insulin resistance in obese humans. Mol Metab. 4:971–976.
2015. View Article : Google Scholar
|
|
26
|
May AA and Woods SC: Is endogenous GLP-1 a
major influence on the orbitofrontal cortex? Mol Metab. 4:977–978.
2015. View Article : Google Scholar
|
|
27
|
Meng J, Ma X, Wang N, Jia M, Bi L, Wang Y,
Li M, Zhang H, Xue X, Hou Z, et al: Activation of GLP-1 receptor
promotes bone marrow stromal cell osteogenic differentiation
through beta-catenin. Stem Cell Reports. 6:6332016. View Article : Google Scholar
|
|
28
|
Yamamoto T, Nakade Y, Yamauchi T,
Kobayashi Y, Ishii N, Ohashi T, Ito K, Sato K, Fukuzawa Y and
Yoneda M: Glucagon-like peptide-1 analogue prevents nonalcoholic
steatohepatitis in non-obese mice. World J gastroenterol.
22:2512–2523. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Seino Y and Yabe D: Glucose-dependent
insulinotropic polypeptide and glucagon-like peptide-1: Incretin
actions beyond the pancreas. J Diabetes Investig. 4:108–130. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Greig NH, Tweedie D, Rachmany L, Li Y,
Rubovitch V, Schreiber S, Chiang YH, Hoffer BJ, Miller J, Lahiri
DK, et al: Incretin mimetics as pharmacologic tools to elucidate
and as a new drug strategy to treat traumatic brain injury.
Alzheimers Dement. 10(Suppl): S62–S75. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Harkavyi A and Whitton PS: Glucagon-like
peptide 1 receptor stimulation as a means of neuroprotection. Br J
Pharmacol. 159:495–501. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Janssens J, Etienne H, Idriss S, Azmi A,
Martin B, Maudsley S and Systems-Level G: Systems-level G
protein-coupled receptor therapy across a neurodegenerative
continuum by the GLP-1 receptor system. Front Endocrinol
(Lausanne). 5:1422014.
|
|
33
|
Li Y, Perry T, Kindy MS, Harvey BK,
Tweedie D, Holloway HW, Powers K, Shen H, Egan JM, Sambamurti K, et
al: GLP-1 receptor stimulation preserves primary cortical and
dopaminergic neurons in cellular and rodent models of stroke and
Parkinsonism. Proc Natl Acad Sci USA. 106:1285–1290. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Salcedo I, Tweedie D, Li Y and Greig NH:
Neuroprotective and neurotrophic actions of glucagon-like
peptide-1: An emerging opportunity to treat neurodegenerative and
cerebrovascular disorders. Br J Pharmacol. 166:1586–1599. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Perry T, Holloway HW, Weerasuriya A,
Mouton PR, Duffy K, Mattison JA and Greig NH: Evidence of
GLP-1-mediated neuroprotection in an animal model of
pyridoxine-induced peripheral sensory neuropathy. Exp Neurol.
203:293–301. 2007. View Article : Google Scholar :
|
|
36
|
Katagi M, Terashima T, Okano J, Urabe H,
Nakae Y, Ogawa N, Udagawa J, Maegawa H, Matsumura K, Chan L, et al:
Hyperglycemia induces abnormal gene expression in hematopoietic
stem cells and their progeny in diabetic neuropathy. FEBS Lett.
588:1080–1086. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yan LJ: Pathogenesis of chronic
hyperglycemia: From reductive stress to oxidative stress. J
Diabetes Res. 2014:1379192014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Purves T, Middlemas A, Agthong S, Jude EB,
Boulton AJ, Fernyhough P and Tomlinson DR: A role for
mitogen-activated protein kinases in the etiology of diabetic
neuropathy. FASEB J. 15:2508–2514. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jiang C and Salton SR: The role of
neurotrophins in major depressive disorder. Transl Neurosci.
4:46–58. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li J, Zhang H, Xie M, Yan L, Chen J and
Wang H: NSE, a potential biomarker, is closely connected to
diabetic peripheral neuropathy. Diabetes Care. 36:3405–3410. 2013.
View Article : Google Scholar : PubMed/NCBI
|
